Publicacións (65) Publicacións de David Dobarro Perez

2024

  1. Repetitive ambulatory levosimendan as a bridge to heart transplantation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301

2023

  1. Durable ventricular assist device in Spain (2007-2020). First report of the REGALAD registry

    Revista Espanola de Cardiologia, Vol. 76, Núm. 4, pp. 227-237

  2. Heart failure risk scores in advanced heart failure patients: insights from the LEVO-D registry

    ESC Heart Failure, Vol. 10, Núm. 5, pp. 2875-2881

  3. Home exercise intervention with the Vivifrail program in frail older patients with heart failure with reduced ejection fraction. The ExFRAIL-HF randomized trial

    Revista Espanola de Cardiologia, Vol. 76, Núm. 11, pp. 939-943

  4. Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?

    International Journal of Cardiology, Vol. 386, pp. 59-64

  5. Impact of dapagliflozin on cardiac remodelling in patients with chronic heart failure: The DAPA-MODA study

    European Journal of Heart Failure, Vol. 25, Núm. 8, pp. 1352-1360

  6. Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry

    ESC Heart Failure, Vol. 10, Núm. 2, pp. 1193-1204

  7. Left Ventricular Assist Device as a Destination Therapy: Current Situation and the Importance of Patient Selection

    Life, Vol. 13, Núm. 4

  8. Selection of the best of 2022 in heart failure

    REC: CardioClinics, Vol. 58, pp. S42-S48

  9. Transcatheter Tricuspid Valve Replacement With a Dedicated Device in a Patient With 2 Endocardial Leads

    JACC: Case Reports, Vol. 15

2022

  1. Acute heart failure in a kidney transplant patient

    Kidney International, Vol. 102, Núm. 1, pp. 211

  2. Selection of the best of 2021 in heart failure

    REC: CardioClinics, Vol. 57, pp. S71-S77

2021

  1. Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy

    European Heart Journal, Vol. 42, Núm. 32, pp. 3063-3073

  2. Carcinoid heart disease and ovarian teratoma

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 135-136

  3. Extra-adrenal paraganglioma. A cause of ventricular dysfunction?

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 141-143

  4. Importance of blood pressure control and adequate neurohormonal treatment in LVAD patients: Comment to paper by Tran T. et al.

    Journal of Heart and Lung Transplantation

  5. Paraganglioma extraadrenal: ¿causa de disfunción ventricular?

    REC: CardioClinics, Vol. 56, Núm. 2, pp. 141-143

2020

  1. Ambulatory levosimendan infusions. Effective and efficient in advanced heart failure?

    Revista Espanola de Cardiologia, Vol. 73, Núm. 5, pp. 345-347

  2. Current prognosis of heart failure in Spain and Europe. A call of attention

    REC: CardioClinics

  3. Durable left ventricular assist device therapy in non transplant centers in Spain: initial experience

    Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 338-340